Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02451553
Title Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Washington
Indications

biliary tract cancer

pancreatic cancer

Advanced Solid Tumor

Therapies

Afatinib

Capecitabine

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Fred Hutch/University of Washington Cancer Consortium Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field